Consistent with previous studies showing deficient expression of IFN-stimulated genes suggesting defective antiviral immune responses in severe COVID-19 (47, 48), type I IFNs including IFN-α2a and IFN-β were not detectable. This evidence concerns the gene IFNA1 and COVID-19.